company background image
SNW logo

Sanofi XTRA:SNW Stock Report

Last Price

€103.40

Market Cap

€129.0b

7D

-0.7%

1Y

19.1%

Updated

07 Feb, 2025

Data

Company Financials +

SNW Stock Overview

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. More details

SNW fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Sanofi Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sanofi
Historical stock prices
Current Share Price€103.40
52 Week High€106.08
52 Week Low€85.00
Beta0.46
1 Month Change8.01%
3 Month Change7.75%
1 Year Change19.10%
3 Year Change10.42%
5 Year Change12.09%
Change since IPO40.32%

Recent News & Updates

Recent updates

Shareholder Returns

SNWDE PharmaceuticalsDE Market
7D-0.7%-3.9%-0.02%
1Y19.1%-12.4%15.1%

Return vs Industry: SNW exceeded the German Pharmaceuticals industry which returned -10.6% over the past year.

Return vs Market: SNW exceeded the German Market which returned 15.3% over the past year.

Price Volatility

Is SNW's price volatile compared to industry and market?
SNW volatility
SNW Average Weekly Movement2.5%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: SNW has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: SNW's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199486,088Paul Hudsonwww.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SNW fundamental statistics
Market cap€128.97b
Earnings (TTM)€5.68b
Revenue (TTM)€44.29b

22.7x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SNW income statement (TTM)
Revenue€44.29b
Cost of Revenue€13.21b
Gross Profit€31.08b
Other Expenses€25.40b
Earnings€5.68b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 24, 2025

Earnings per share (EPS)4.55
Gross Margin70.18%
Net Profit Margin12.83%
Debt/Equity Ratio20.5%

How did SNW perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

86%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:55
End of Day Share Price 2025/02/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sanofi is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
John EadeArgus Research Company
Odile RundquistBaader Helvea Equity Research